Annual Total Long Term Liabilities
$0.00
-$19.80 K-100.00%
September 30, 2024
Summary
- As of February 12, 2025, EDSA annual total long term liabilities is $0.00, with the most recent change of -$19.80 thousand (-100.00%) on September 30, 2024.
- During the last 3 years, EDSA annual total long term liabilities has fallen by -$67.70 thousand (-100.00%).
- EDSA annual total long term liabilities is now -100.00% below its all-time high of $6.84 million, reached on August 31, 2013.
Performance
EDSA Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Long Term Liabilities
$0.00
$0.000.00%
September 30, 2024
Summary
- As of February 12, 2025, EDSA quarterly total long term liabilities is $0.00, unchanged on September 30, 2024.
- Over the past year, EDSA quarterly long term liabilities has stayed the same.
- EDSA quarterly long term liabilities is now -100.00% below its all-time high of $7.23 million, reached on November 30, 2013.
Performance
EDSA Quarterly Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Long Term Liabilities Formula
Long-Term Liabilities = Long-Term Debt + Deferred Tax Liabilities + Pension Liabilities + Other Long-Term Liabilities
EDSA Long Term Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -100.0% | 0.0% |
| 3 y3 years | -100.0% | -100.0% |
| 5 y5 years | 0.0% | -100.0% |
EDSA Long Term Liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -100.0% | at low | -100.0% | at low |
| 5 y | 5-year | -100.0% | at low | -100.0% | at low |
| alltime | all time | -100.0% | at low | -100.0% | at low |
Edesa Biotech Long Term Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | $0.00(-100.0%) | $0.00(0.0%) |
| Jun 2024 | - | $0.00(0.0%) |
| Mar 2024 | - | $0.00(0.0%) |
| Dec 2023 | - | $0.00(-100.0%) |
| Sep 2023 | $19.80 K(-54.7%) | $19.80 K(-50.6%) |
| Jun 2023 | - | $40.10 K(-63.1%) |
| Mar 2023 | - | $108.80 K(-10.0%) |
| Dec 2022 | - | $120.90 K(+176.7%) |
| Sep 2022 | $43.70 K(-35.5%) | $43.70 K(-6.0%) |
| Jun 2022 | - | $46.50 K(-3.1%) |
| Mar 2022 | - | $48.00 K(+1.7%) |
| Dec 2021 | - | $47.20 K(-30.3%) |
| Sep 2021 | $67.70 K(-97.4%) | $67.70 K(-24.9%) |
| Jun 2021 | - | $90.10 K(-17.2%) |
| Mar 2021 | - | $108.80 K(-92.7%) |
| Dec 2020 | - | $1.50 M(-42.4%) |
| Sep 2020 | $2.60 M(>+9900.0%) | $2.60 M(+0.1%) |
| Jun 2020 | - | $2.60 M(+2017.0%) |
| Mar 2020 | - | $122.70 K(-19.0%) |
| Dec 2019 | - | $151.50 K(>+9900.0%) |
| Sep 2019 | $0.00(0.0%) | - |
| Jun 2019 | - | $0.00(0.0%) |
| Mar 2019 | - | $0.00(0.0%) |
| Dec 2018 | - | $0.00(0.0%) |
| Sep 2018 | $0.00(0.0%) | $0.00(0.0%) |
| Jun 2018 | - | $0.00(0.0%) |
| Mar 2018 | - | $0.00(0.0%) |
| Dec 2017 | - | $0.00(0.0%) |
| Sep 2017 | $0.00 | $0.00(0.0%) |
| Jun 2017 | - | $0.00(0.0%) |
| Mar 2017 | - | $0.00(0.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2016 | - | $0.00(0.0%) |
| Sep 2016 | $0.00(0.0%) | $0.00(0.0%) |
| Jun 2016 | - | $0.00(0.0%) |
| Mar 2016 | - | $0.00(0.0%) |
| Dec 2015 | - | $0.00(0.0%) |
| Sep 2015 | $0.00(-100.0%) | $0.00(0.0%) |
| Jun 2015 | - | $0.00(0.0%) |
| Mar 2015 | - | $0.00(-100.0%) |
| Dec 2014 | - | $233.60 K(-95.6%) |
| Sep 2014 | $3.69 M(-31.0%) | - |
| Aug 2014 | $5.35 M(-21.7%) | $5.35 M(+60.7%) |
| May 2014 | - | $3.33 M(-41.0%) |
| Feb 2014 | - | $5.64 M(-22.0%) |
| Nov 2013 | - | $7.23 M(+5.8%) |
| Aug 2013 | $6.84 M(+5153.8%) | $6.84 M(+36.4%) |
| May 2013 | - | $5.01 M(+20.7%) |
| Feb 2013 | - | $4.15 M(+354.6%) |
| Nov 2012 | - | $913.40 K(+602.1%) |
| Aug 2012 | $130.10 K(-91.5%) | $130.10 K(+11.0%) |
| May 2012 | - | $117.20 K(-67.6%) |
| Feb 2012 | - | $361.80 K(-41.9%) |
| Nov 2011 | - | $623.00 K(-59.2%) |
| Aug 2011 | $1.53 M(+91.6%) | $1.53 M(>+9900.0%) |
| May 2011 | - | $0.00(0.0%) |
| Feb 2011 | - | $0.00(0.0%) |
| Nov 2010 | - | $0.00(-100.0%) |
| Aug 2010 | $797.30 K(>+9900.0%) | $797.30 K(>+9900.0%) |
| May 2010 | - | $0.00(0.0%) |
| Jan 2010 | - | $0.00(0.0%) |
| Oct 2009 | - | $0.00(0.0%) |
| Apr 2009 | $0.00(0.0%) | $0.00 |
| Apr 2008 | $0.00 | - |
FAQ
- What is Edesa Biotech annual total long term liabilities?
- What is the all time high annual total long term liabilities for Edesa Biotech?
- What is Edesa Biotech annual total long term liabilities year-on-year change?
- What is Edesa Biotech quarterly total long term liabilities?
- What is the all time high quarterly long term liabilities for Edesa Biotech?
- What is Edesa Biotech quarterly long term liabilities year-on-year change?
What is Edesa Biotech annual total long term liabilities?
The current annual total long term liabilities of EDSA is $0.00
What is the all time high annual total long term liabilities for Edesa Biotech?
Edesa Biotech all-time high annual total long term liabilities is $6.84 M
What is Edesa Biotech annual total long term liabilities year-on-year change?
Over the past year, EDSA annual total long term liabilities has changed by -$19.80 K (-100.00%)
What is Edesa Biotech quarterly total long term liabilities?
The current quarterly long term liabilities of EDSA is $0.00
What is the all time high quarterly long term liabilities for Edesa Biotech?
Edesa Biotech all-time high quarterly total long term liabilities is $7.23 M
What is Edesa Biotech quarterly long term liabilities year-on-year change?
Over the past year, EDSA quarterly total long term liabilities has changed by $0.00 (0.00%)